Condition
Breast Masses
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Not Yet Recruiting2
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07268300Not Yet RecruitingPrimary
Breast Masses MRI Volumetry Compared to Post-operative Pathological Volume
NCT06908291Not ApplicableRecruitingPrimary
Photoacoustic/Ultrasound Imaging for Breast Nodule Diagnosis, Molecular Classification, and Neoadjuvant Chemotherapy Response Evaluation
NCT06175078Not Yet Recruiting
Three-Dimensional Ultrasound Imaging and Spectroscopy for Characterizing Breast Masses
Showing all 3 trials